Literature DB >> 26064326

Histological grade of hepatocellular carcinoma predicted by quantitative diffusion-weighted imaging.

Weihua Guo1, Suhong Zhao1, Yuhai Yang1, Guangrui Shao1.   

Abstract

OBJECTIVE: This study is to evaluate the application of diffusion-weighted imaging (DWI) in determining the histological grade of hepatocellular carcinoma (HCC).
METHODS: Totally, 27 HCC patients who received DWI examination before surgical resection were included in this study. Relationships of apparent diffusion coefficient (ADC) and signal intensity (SI) with the histological grade of HCC were analyzed.
RESULTS: These 27 HCC patients could be classified into 6 well, 10 moderately, and 11 poorly differentiated HCCs. The overall ADC value for all HCC cases was (1.28 ± 0.19) × 10(-3) mm(2)/s. The ADC value for poorly differentiated HCCs was (1.16 ± 0.16) × 10(-3) mm(2)/s, significantly lower than the well [(1.43 ± 0.09) × 10(-3) mm(2)/s] and moderately [(1.34 ± 0.19) × 10(-3) mm(2)/s] differentiated HCCs. There was no significant difference in ADC between the well and moderately differentiated HCCs. The overall SI value for all the HCC cases was 75.66 ± 32.94. The mean SI value for the moderately differentiated HCC cases was 54.37 ± 28.37, significantly lower than the well (90.78 ± 27.49) and poorly (86.77 ± 31.51) differentiated HCCs. No significant difference in SI was observed between the well and poorly differentiated HCCs. Additionally, there was a significant negative correlation between the ADC value and the histological grade of HCC.
CONCLUSION: The ADC value based on DWI is useful in determining the histological grade of HCC, while the SI value provides limited contribution to HCC histological grade evaluation.

Entities:  

Keywords:  Hepatocellular carcinoma; apparent diffusion coefficient (ADC); diffusion-weighted imaging (DWI); histological grading; magnetic resonance imaging (MRI); signal intensity (SI)

Year:  2015        PMID: 26064326      PMCID: PMC4443160     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

1.  Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma.

Authors:  Akihiro Nishie; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Daisuke Kakihara; Tomohiro Nakayama; Yukihisa Takayama; Daisuke Okamoto; Nobuhiro Fujita; Akinobu Taketomi; Kengo Yoshimitsu; Hiroshi Honda
Journal:  Eur J Radiol       Date:  2010-07-08       Impact factor: 3.528

Review 2.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

3.  Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants--initial experience.

Authors:  Chiao-Yun Chen; Chun-Wei Li; Yu-Ting Kuo; Twei-Shiun Jaw; Ding-Kwo Wu; Jo-Chi Jao; Jui-Sheng Hsu; Gin-Chung Liu
Journal:  Radiology       Date:  2006-03-28       Impact factor: 11.105

Review 4.  Hepatocellular carcinoma: clinicopathological aspects.

Authors:  K Okuda
Journal:  J Gastroenterol Hepatol       Date:  1997-10       Impact factor: 4.029

Review 5.  Diffusion-weighted MRI of adult male pelvic cancers.

Authors:  K S Lim; C H Tan
Journal:  Clin Radiol       Date:  2012-04-11       Impact factor: 2.350

6.  Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.

Authors:  Yasuji Komorizono; Makoto Oketani; Katsumi Sako; Naruhiro Yamasaki; Toshihiko Shibatou; Masahiko Maeda; Kazunori Kohara; Shuhou Shigenobu; Kazuaki Ishibashi; Terukatsu Arima
Journal:  Cancer       Date:  2003-03-01       Impact factor: 6.860

7.  Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor.

Authors:  Suk Hee Heo; Yong Yeon Jeong; Sang Soo Shin; Jin Woong Kim; Hyo Soon Lim; Jae Hyuk Lee; Yang Seok Koh; Chol Kyoon Cho; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

8.  Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.

Authors:  Taro Takahara; Yutaka Imai; Tomohiro Yamashita; Seiei Yasuda; Seiji Nasu; Marc Van Cauteren
Journal:  Radiat Med       Date:  2004 Jul-Aug

Review 9.  Diffusion-weighted MRI in the body: applications and challenges in oncology.

Authors:  Dow-Mu Koh; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

Review 10.  Diffusion-weighted MRI of hepatocellular carcinoma in cirrhosis.

Authors:  K S Lim
Journal:  Clin Radiol       Date:  2013-09-10       Impact factor: 2.350

View more
  17 in total

1.  Prediction of histological grade of hepatocellular carcinoma using quantitative diffusion-weighted MRI: a retrospective multivendor study.

Authors:  Yusuke Ogihara; Yoshio Kitazume; Yoshihiro Iwasa; Shinichi Taura; Yoshiro Himeno; Tomo Kimura; Seishi Sawano; Shigehiko Terada; Minoru Tanabe; Yukihisa Saida; Ukihide Tateishi
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

2.  Benefits of the 8th American Joint Committee on Cancer System for Hepatocellular Carcinoma Staging.

Authors:  Catalin Bogdan Satala; Decebal Fodor; Ioan Jung; Laszlo Kobori; Zsolt Kovacs; Rita Szodorai; Simona Gurzu
Journal:  J Gastrointest Cancer       Date:  2021-03

Review 3.  Diffusion-weighted magnetic resonance imaging in cancer: Reported apparent diffusion coefficients, in-vitro and in-vivo reproducibility.

Authors:  Maysam M Jafar; Arman Parsai; Marc E Miquel
Journal:  World J Radiol       Date:  2016-01-28

Review 4.  Diffusion-Weighted Imaging Reflects Tumor Grading and Microvascular Invasion in Hepatocellular Carcinoma.

Authors:  Alexey Surov; Maciej Pech; Jazan Omari; Frank Fischbach; Robert Damm; Katharina Fischbach; Maciej Powerski; Borna Relja; Andreas Wienke
Journal:  Liver Cancer       Date:  2021-01-27       Impact factor: 11.740

Review 5.  Diffusion-weighted imaging of the liver: Current applications.

Authors:  Kazuhiro Saito; Yu Tajima; Taiyo L Harada
Journal:  World J Radiol       Date:  2016-11-28

6.  Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for Hepatocellular carcinoma: correlation with histologic grade.

Authors:  Vincenza Granata; Roberta Fusco; Orlando Catalano; Benedetta Guarino; Francesco Granata; Fabiana Tatangelo; Antonio Avallone; Mauro Piccirillo; Raffaele Palaia; Francesco Izzo; Antonella Petrillo
Journal:  Oncotarget       Date:  2016-11-29

7.  Histological Grading of Hepatocellular Carcinomas with Intravoxel Incoherent Motion Diffusion-weighted Imaging: Inconsistent Results Depending on the Fitting Method.

Authors:  Shintaro Ichikawa; Utaroh Motosugi; Diego Hernando; Hiroyuki Morisaka; Nobuyuki Enomoto; Masanori Matsuda; Hiroshi Onishi
Journal:  Magn Reson Med Sci       Date:  2017-08-16       Impact factor: 2.471

8.  Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.

Authors:  Shao-Cheng Zhu; Yue-Hua Liu; Yi Wei; Lin-Lin Li; She-Wei Dou; Ting-Yi Sun; Da-Peng Shi
Journal:  World J Gastroenterol       Date:  2018-02-28       Impact factor: 5.742

Review 9.  CT-MRI LI-RADS v2017: A Comprehensive Guide for Beginners.

Authors:  Francesca Patella; Filippo Pesapane; Enrico Maria Fumarola; Ilaria Emili; Riccardo Spairani; Salvatore Alessio Angileri; Silvia Tresoldi; Giuseppe Franceschelli; Gianpaolo Carrafiello
Journal:  J Clin Transl Hepatol       Date:  2018-02-22

10.  Apparent diffusion coefficient of hepatocellular carcinoma on diffusion-weighted imaging: Histopathologic tumor grade versus arterial vascularity during dynamic magnetic resonance imaging.

Authors:  In Kyung Park; Jeong-Sik Yu; Eun-Suk Cho; Joo Hee Kim; Jae-Joon Chung
Journal:  PLoS One       Date:  2018-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.